In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 3, 2003, Pages 576-582

  Dobrowsky, Werner ^a,b   Dobrowsky, Eva ^c   Wilson, George D ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Accelerated radiotherapy; Cell kinetics; Mitomycin C; Randomized trial

Indexed keywords

BIOLOGICAL ORGANS; CELLS; PATIENT TREATMENT; TUMORS;

CELL KINETIC PARAMETERS;

RADIOTHERAPY;

BROXURIDINE; MITOMYCIN;

ARTICLE; CANCER SURVIVAL; CELL KINETICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; LABELING INDEX; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

EID: 0037358375     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04121-4     Document Type: Article

References (28)

1. Awwad H.K., Khafagy Y., Barsoum M., et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer Influence of tumour proliferation . Radiother Oncol. 25:1992;261-266.
2. Begg A.C., Hofland I., Moonen L., et al. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors An interim report . Int J Radiat Oncol Biol Phys. 19:1990;1449-1453.
3. Begg A.C., Haustermans K., Hart A.A., et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer A multicenter analysis . Radiother Oncol. 50:1999;13-23.
4. Bourhis J., Dendale R., Hill C., et al. Potential doubling time and clinical outcome in head, and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys. 35:1996;471-476.
5. Corvo R., Giaretti W., Sanguineti G., et al. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol. 13:1995;1843-1850.
6. Corvo R., Giaretti W., Geido E., et al. Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas. Int J Cancer. 68:1996;151-155.
7. Corvo R., Giaretti W., Sanguineti G., et al. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas. Clin Cancer Res. 3:1997;1993-1997.
8. Hoyer M., Jorgensen K., Bundgaard T., et al. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck. Radiother Oncol. 46:1998;147-155.
9. Wilson G.D., Dische S., Saunders M.I. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol. 36:1995;189-197.
10. Zackrisson B., Gustafsson H., Stenling R., et al. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys. 38:1997;677-683.
11. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
12. Dobrowsky W., Dobrowsky E., Naude J., et al. Conventional vs accelerated fractionation in head and neck cancer. Br J Cancer Suppl. 27:1996;S279-S281.
13. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head, and neck cancers. Results of the EORTC 22851 randomized trial. [see comments] Radiother Oncol. 44:1997;111-121.
14. Saunders M., Dische S., Barrett A., et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer. Mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol. 52:1999;137-148.
15. Dobrowsky W., Naude J., Dobrowsky E., et al. Mitomycin C (MMC), and unconventional fractionation (V-CHART) in advanced head, and neck cancer. Acta Oncol. 34:1995;270-272.
16. Wilson G.D., Paschoud N., Pavy J.J., et al. Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045. Br J Cancer. 79:1999;323-332.
17. Dobrowsky W., Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol. 57:2000;119-124.
18. Struikmans H., Rutgers D.H., Hordijk G.J., et al. Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors. Int J Radiat Oncol Biol Phys. 40:1998;27-34.
19. Haustermans K., Hofland I., Pottie G., et al. Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study. Cytometry. 19:1995;154-163.
20. Wilson M.S., West C.M., Wilson G.D., et al. An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer. 67:1993;754-759.
21. Bennett M.H., Wilson G.D., Dische S., et al. Tumour proliferation assessed by combined histological and flow cytometric analysis Implications for therapy in squamous cell carcinoma in the head and neck . Br J Cancer. 65:1992;870-878.
22. Rew D.A., Wilson G.D. Cell production rates in human tissues and tumours and their significance. Part II Clinical data . Eur J Surg Oncol. 26:2000;405-417.
23. Pihan G.A., Doxsey S.J. The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol. 9:1999;289-302.
24. El-Naggar A.K., Hurr K., Huff V., et al. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma Association with aggressive biological features . Clin Cancer Res. 2:1996;903-907.
25. Amiel A., Kolodizner T., Fishman A., et al. Replication pattern of the p53 and 21q22 loci in the premalignant and malignant stages of carcinoma of the cervix. Cancer. 83:1998;1966-1971.
26. Goldman M.A., Holmquist G.P., Gray M.C., et al. Replication timing of genes and middle repetitive sequences. Science. 224:1984;686-692.
27. Hatton K.S., Dhar V., Brown E.H., et al. Replication program of active and inactive multigene families in mammalian cells. Mol Cell Biol. 8:1988;2149-2158.
28. Rhind N., Russell P. Checkpoints It takes more than time to heal some wounds . Curr Biol. 10:2000;R908-R911.